Risk factors of bone mineral density deficit and low-energy fractures in primary osteoporosis in men

Full Text


Purpose: to evaluate the role of well-known factors on the formation of bone mineral density (BMD) and risk of fractures in primary osteoporosis in men. Patients and methods. The influence of well-known osteoporosis risk factors such as age, smoking, alcohol consumption, obesity, genetic disorders in genes encoding COL1A1, COL1A2 and VDR-receptor products, history of low-energy fractures in first-line relatives upon the BMD value and risk of fractures was evaluated in 231 patients with primary osteoporosis. All patients were divided into three age groups according to the following forms of osteoporosis: 17-20 years (n=26) - juvenile form, 21-50 (n=103) - idiopathic form, patients over 51 years (n=102). To assess the influence of study factors on the risk of fractures the patients were subdivided into 5 groups according to fracture localization. Results. The relationship between BMD deficit and mutations in homozygous form of gene rs2412298 (encodes collagen), and the tendency to a reliable increase of BMD deficit in L1 - L4 vertebrae under polymorphism in homozygous form of 1800012 gene was noted that might be evidence of their contribution to the development of primary osteoporosis in men. At the same time, smoking, alcohol consumption, age, mutations in homozygous form of gene rs2412298 and a history of low-energy fractures in first-line relatives increased the risk of low-energy fractures of the vertebral bodies and proximal femur.

Full Text

Restricted Access

About the authors

Svetlana S. Rodionova

N.N. Priorov National Medical Research Center of Traumatology and Orthopaedics

Email: rod06@inbox.ru
Dr. med. sci., Prof., Head of Osteoporosis Center, N.N. Priorov NMRC TO Moscow, Russia

U. R Khakimov

N.N. Priorov National Medical Research Center of Traumatology and Orthopaedics

Moscow, Russia


  1. Svedbom A., Hernlund E., Ivergård M. et al. Review Panel of IOF Osteoporosis in the European Union: a compendium of country-specific reports. Arch. Osteoporos. 2013; 8: 137. doi: 10.1007/s11657-013-0137-0.
  2. Кanis J. Who and when to treat? Osteoporos Int. 2017; 28 (Supp1): 585-7.
  3. Лесняк О.М. Актуальные вопросы диагностики и лечения остеопороза у мужчин в амбулаторной практике. Российский семейный врач. 2017; 21 (1): 39-44.
  4. Торопцова Н.В. Остеопороз: взгляд на проблему диагностики и лечения. Современная ревматология. 2009; 3 (9): 68-72.
  5. Giusti A., Bianchi G. Treatment of primary osteoporosis in men. Clin. Interv. Aging. 2014; 10: 105-15. doi: 10.2147/CIA.S44057.
  6. Franke J., Runge H. Osteoporosis. Berlin: Veb Verlag Volk & Gesundheit; 1987.
  7. Kanis J., McCloskey E., Johansson H. et al. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos. Int. 2013; 24 (1): 23-57. doi: 10.1007/s00198-012-2074-y.
  8. Sheu Y., Bunker C.H., Jonnalagadda P. et al. Rates of and risk factors for trabecular and cortical BMD loss in middle-aged and elderly African-ancestry men. J. Bone Miner. Res. 2015; 30 (3): 543-53. doi: 10.1002/jbmr.2359.
  9. ISCD Official Positions - Adult. Available at https://www.iscd.org/official-positions/2015-iscd-official-positions-adult.
  10. Кривова А.В. Оптимизация диагностики остеопороза и профилактики низкоэнергетических переломов на региональном уровне (тверская область): Дис. … д-ра мед. наук. М.; 2012.
  11. Schürer C., Wallaschofski H., Nauck M. et al. Fracture risk and risk factors for osteoporosis. Dtsch Arztebl Int. 2015; 112 (21-22): 365-71. doi: 10.3238/arztebl.2015.0365.
  12. Matsuo K., Hirohata T., Sugioka Y. et al. Influence of alcohol intake, cigarette smoking, and occupational status on idiopathic osteonecrosis of the femoral head. Clin. Orthop. Relat. Res. 1988; (234): 115-23.
  13. Peterson K. Biomarkers for alcohol use and abuse--a summary. Alcohol Res. Health. 2004-2005; 28 (1): 30-7.
  14. Johnsoh M.L., Lara N., Kamel M.A. How genomics has informed our understanding of the pathogenesis of osteoporosis. Genome Med. 2009; 1 (9): 84. doi: 10.1186/gm84.
  15. Ding Z., Chen Y., Xu Y. et al. Impact of age, gender, and body composition on bone quality in an adult population from the middle areas of China. J. Clin. Densitom. 2018: 21 (1): 83-90.
  16. Bianchi G., Kendler D., Leung P. et al. Effect of once-yearly zoledronic acid on the spine and hip as measured by quantitative computed tomography: results of the HORIZON Pivotal Fracture Trial. Osteoporos. Int. 2010; 21 (7): 1277-85.
  17. Рзаев М.М. Остеопороз у лиц мужского пола и прогностическая значимость факторов риска при переломах разной локализации: Автореф. дис. … канд. мед. наук. Новосибирск;.
  18. Скрипникова И.А., Гурьев А.В., Шальнова С.А. и др. Распространенность клинических факторов, используемых для оценки риска остеопоротических переломов. Профилактическая медицина. 2016; 5: 32-40. doi: 10.17116/profmed201619532-40.



Abstract: 134


Article Metrics

Metrics Loading ...



  • There are currently no refbacks.

Copyright (c) 2018 Eco-Vector

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies